Product Roadmap

CareEZ Roadmap

Where we are, where we're going — and what depends on what. This roadmap is tied to the HKEX IFS 2026 award; conditional phases are marked clearly.

Shipped
In progress
Planned
Conditional (post-award)
2026-05 · Pre-launch
Y0 — Foundation
✅ Shipped
✅10 live API endpoints (text / image / voice / audio / recipe / batch / clinical-QA / WhatsApp / leads / biomarker-Cantonese)
✅5 public web properties — careez.org, demo, seniordeli/careez, Softmeal, dysphagia.cn
✅HKEX IFS 2026 submission bundle complete
✅Snap-to-IDDSI Claude Vision activated (4/8 baseline)
✅Brand consolidation: CareForge → CareEZ
✅Adoption Index dashboard public
Nov 2026 → Jan 2027
Y1 Q1 — Pilots Launch
⏸ Conditional
⏸HKU + Full Linkage MOU signing
⏸3 RCHE pilots active
⏸200 carers IDDSI certified
⏸Vision fine-tune: 50% → 75% accuracy
⏸Voice biomarker IRB submission (HKU)
Feb – Apr 2027
Y1 Q2 — Scale & Data
⏸ Conditional
⏸+2 pilot RCHEs (5 total)
⏸1,000 carers certified
⏸Voice biomarker data collection wave 1 (N=150)
⏸Q1 Adoption Index report published
⏸FDH onboarding — Tagalog / Bahasa pilot
May – Jul 2027
Y1 Q3 — Vision Deploy & NGOs
⏸ Conditional
⏸2,500 carers certified
⏸Vision model deploy with fine-tune
⏸Voice biomarker data collection wave 2
⏸OpenClaw 6 packages npm publish (delayed from Y0)
⏸Tier 1 NGO partner enrollment (15 NGOs)
Aug – Oct 2027
Y1 Q4 — Y1 Target & Commercial
⏸ Conditional
⏸5,000 carers certified (Y1 target met)
⏸Voice biomarker preliminary report
⏸Recipe Modifier production-grade (40+ recipes)
⏸Q2 + Q3 Adoption Index reports
⏸Tier 2 commercial pilots (3–5 RCHEs paying)
Nov 2027 → Oct 2028
Y2 — GBA Expansion & Revenue
⏸ Conditional
⏸Adoption Index Q4 2028 target: 50%
⏸Voice biomarker API deployment
⏸Multilingual: +10 languages
⏸Cross-region: Macau + Shenzhen pilots
⏸B2B SaaS Tier 2+ revenue: HK$3–5M ARR target
Beyond 2028
Y3+ — Broader Impact
⚪ Planned
⚪Replicate model to other elderly conditions (fall risk, medication adherence)
⚪Cross-border: Singapore, Malaysia, Indonesia, Vietnam
⚪Acoustic biomarker FDA clearance investigation

How we'll be honest

  • This roadmap is conditional on the HKEX IFS 2026 award + pilot RCHE recruitment.
  • Without award: pivots to Y0.5 self-funded reduced scope — no fine-tune, no biomarker study, voluntary RCHE pilots only.
  • Monthly progress reports at careez.org/changelog/